Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03
British Journal of Cancer, 10/01/09
Kishida Y et al. – Chemotherapy–induced neutropenia is a predictor of better survival for patients with advanced NSCLC. Prospective randomised trials of early–dose increases guided by chemotherapy–induced toxicities are warranted.
Related Articles
Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: A retrospective chart review
Clinical Therapeutics, 10/29/09
Relevance Score: 91%
Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies
Critical Care, 11/06/09
Relevance Score: 90%
Antibiotic-induced Severe Neutropenia with Multidrug-Dependent Antineutrophil Antibodies Developed in A Child with Streptococcus pneumoniae Infection
Journal of Korean Medical Science, 10/06/09
Relevance Score: 83%
Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia
British Journal of Haematology, 10/05/09
Relevance Score: 82%
Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study
Journal of Clinical Oncology, 10/23/09
Relevance Score: 80%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is there a role for intensifying induction therapy in acute myeloid leukaemia (AML)?
Best Practice & Research: Clinical Haematology , 12/08/09
New agents for AML and MDS
Best Practice & Research: Clinical Haematology , 12/08/09
Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/08/09
Sponsor
Article Search
Sponsor


See Latest Articles


